Skip to main navigation Skip to search Skip to main content

Annexin A2 antibodies but not inhibitors of the annexin A2 heterotetramer impair productive HIV-1 infection of macrophages in vitro

  • Andrew W. Woodham
  • , Adriana M. Sanna
  • , Julia R. Taylor
  • , Joseph G. Skeate
  • , Diane M. Da Silva
  • , Lodewijk V. Dekker
  • , W. Martin Kast

Research output: Contribution to journalArticleResearchpeer-review

Abstract

During sexual transmission of human immunodeficiency virus (HIV), macrophages are initial targets for HIV infection. Secretory leukocyte protease inhibitor (SLPI) has been shown to protect against HIV infection of macrophages through interactions with annexin A2 (A2), which is found on the macrophage cell surface as a heterotetramer (A2t) consisting of A2 and S100A10. Therefore, we investigated potential protein-protein interactions between A2 and HIV-1 gp120 through a series of co-immunoprecipitation assays and a single molecule pulldown (SiMPull) technique. Additionally, inhibitors of A2t (A2ti) that target the interaction between A2 and S100A10 were tested for their ability to impair productive HIV-1 infection of macrophages. Our data suggest that interactions between HIV-1 gp120 and A2 exist, though this interaction may be indirect. Furthermore, an anti-A2 antibody impaired HIV-1 particle production in macrophages in vitro, whereas A2ti did not indicating that annexin A2 may promote HIV-1 infection of macrophages in its monomeric rather than tetrameric form.

Original languageEnglish
Pages (from-to)1-5
Number of pages5
JournalVirology Journal
Volume13
Issue number1
DOIs
Publication statusPublished - 18 Nov 2016
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Annexin A2
  • Annexin A2 heterotetramer
  • HIV-1
  • Inhibitor
  • Macrophage
  • Receptor

Cite this